Orbifloxacin
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.166.510 |
| Chemical and physical data | |
| Formula | C19H20F3N3O3 |
| Molar mass | 395.382 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1][2] marketed by Schering-Plough Animal Health.
See also

References
- ^ "Product Abstract - NADA 141-081". American College of Veterinary Clinical Pharmacology. Retrieved 21 June 2008.
- ^ Papich MG (October 2020). "Orbifloxacin". Papich Handbook of Veterinary Drugs (Fifth ed.). St. Louis, Missouri: Elsevier Health Sciences. p. 674. ISBN 978-0-323-70958-3.
